Cargando…
Left Ventricular Assist Devices in Patients With Active Malignancies
BACKGROUND: There are limited data to guide oncology and cardiology decision-making in patients with a left ventricular assist device (LVAD) and concurrent active malignancy. OBJECTIVES: The goal of this study was to describe cancer treatment approaches, complications, and survival among patients wi...
Autores principales: | Schlam, Ilana, Lee, Andy Y., Li, Song, Sheikh, Farooq H., Zaghlol, Raja, Basyal, Binaya, Gallagher, Christopher, Molina, Ezequiel, Mahr, Claudius, Cheng, Richard K., Barac, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352017/ https://www.ncbi.nlm.nih.gov/pubmed/34396339 http://dx.doi.org/10.1016/j.jaccao.2021.04.008 |
Ejemplares similares
-
Intra‐Aortic Balloon Pump as a Bridge to Durable Left Ventricular Assist Device
por: Brown, Matthew A., et al.
Publicado: (2021) -
Pathophysiology and management of valvular disease in patients with destination left ventricular assist devices
por: Dimarakis, Ioannis, et al.
Publicado: (2022) -
Right heart failure after left ventricular assist device: From mechanisms to treatments
por: Bravo, Claudio A., et al.
Publicado: (2022) -
Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom
por: Schueler, Stephan, et al.
Publicado: (2021) -
Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist Device
por: Silvestry, Scott C., et al.
Publicado: (2020)